JPRN-UMIN000016249已完成未知
Comparison of efficacy and safety of azilsartan and olmesartan in patients with essential hypertension - CANZONE study
Department of Cardiology, Fukuoka University School of Medicine0 个研究点目标入组 60 人开始时间: 2015年1月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Severe liver dysfunction. 2.Severe renal dysfunction. 3.Pregnancy or lactation in women. 4.Patients with a history of allergy to any component of the study medications. 5.Patients corresponding to the contraindication of study medications. 6.Ineligible patients according to the judgment by physician.
研究者
相似试验
尚未招募
4 期
Effect of drug intervention on hypertensive patientsCTRI/2019/11/021961All India Institute of medical Sciences
已完成
不适用
A clinical trial to study the effects of two drugs,Azilsartan and Losartan in patients with high blood pressureCTRI/2020/08/027209PIMS105
招募中
不适用
Evaluation for Efficacy and Safety of Azilsartan in Patients with HypertensioEssential HypertensionJPRN-UMIN000008577Department of Medicine and Bioregulatory SciencesThe University of Tokushima, Graduate School of Health Biosciences30
尚未招募
4 期
TO COMPARE THE SAFETY & EFFICACY OF AZILSARTAN VERSUS OLMESARTAN AS ADD ON THERAPY TO CHLORTHALIDONE IN COEXISTING HYPERTENSION WITH TYPE-2 DIABETES MELLITUS RANDOMISED CONTROLLED TRIACTRI/2020/04/024756DR DEEKSHA SHARMA
已完成
不适用
Efficacy and safety of treatment with Azilsartan in type 2 diabetes mellitus patients with hypertension who did not show target blood pressure by telmisartan.Type 2 diabetes mellitus with hypertensionJPRN-UMIN000010604Iwasaki Naika Clinic20